ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/21/2025
Back to search
Official data from USPTO
SINEUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/27/2025
Trademark type
Word
Nice classes
1, 5
Filing date
01/22/2021
Registration date
01/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2023
Last transaction
03/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
JANSON, ANDREW
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Harness Therapeutics Limited
Transine Therapeutics Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemical preparations for scientific purposesother than for medical or veterinary use; chemicals for research usenucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research usenucleic acid sequences for laboratory usenucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNAreagents for scientific purposesother than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNAenzymes for scientific and research purposes; molecular biology research tools in the nature of biologicalchemical and biochemical reagents for research use
Class 5
Pharmaceutical preparations for the treatment and prevention of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; biologicalchemical and biochemical reagentsDNA and RNA sequences and gene editing enzymesall for medical use; DNA and RNA products for medical usenucleic acid sequences for medical purposes; therapeutic DNA and RNAnucleic acid sequences for medical purposes
Publications
History of USPTO decisions and trademark events.
39 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2023
FIMP
FINAL DISPOSITION PROCESSED
05/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2022
PUBO
PUBLISHED FOR OPPOSITION
11/15/2022
GPNX
NOTIFICATION PROCESSED BY IB
11/14/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/26/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/13/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/20/2022
DOCK
ASSIGNED TO EXAMINER
09/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/31/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/31/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/20/2022
DOCK
ASSIGNED TO EXAMINER
07/15/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2022
GNFR
FINAL REFUSAL E-MAILED
04/14/2022
CNFR
FINAL REFUSAL WRITTEN
04/14/2022
DOCK
ASSIGNED TO EXAMINER
03/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2022
RFNT
REFUSAL PROCESSED BY IB
09/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/25/2021
RFRR
REFUSAL PROCESSED BY MPU
08/25/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2021
CNRT
NON-FINAL ACTION WRITTEN
08/11/2021
DOCK
ASSIGNED TO EXAMINER
08/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/25/2021
Continuous trademark protection
Get notified about every new filing that threatens SINEUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.